Table 3 Neonatal outcomes
Characteristic | Dydrogesterone group (n = 24) | Placebo group (n = 24) | p value |
|---|---|---|---|
Birth weight (grams) | 2544.5 ± 734.2 | 2649.2 ± 674.8 | 0.614 |
Apgar score | |||
At 1 min < 7 | 2 (8.3 %) | 4 (16.7 %) | 0.666 |
At 5 min < 7 | 0 | 1 (4.2 %) | 1.000 |
Neonatal complication | |||
RDS | 6 (25 %) | 3 (12.5 %) | 0.461 |
IVH | 0 | 0 | NA |
NEC | 0 | 0 | NA |
Sepsis | 3 (12.5 %) | 6 (25 %) | 0.461 |
AOP | 1 (4.2 %) | 1 (4.2 %) | 1.000 |
TTNB | 1 (4.2 %) | 1 (4.2 %) | 1.000 |
NICU Admission | 7 (25 %) | 5 (16.7 %) | 0.504 |